SLE resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 47: Line 47:


=== Diagnostic criteria: ===
=== Diagnostic criteria: ===
In 2012, Systemic Lupus International Collaboration Criteria (SLICC) developed a new criteria for SLE diagnosis. SLICC criteria for the classification of [[systemic lupus erythematosus]] was developed based on the old ACR criteria for the classification of [[systemic lupus erythematosus]] to address a more sensitive diagnostic criteria and also to cover weaknesses of the previous ACR criteria.<ref name="pmid7138600">{{cite journal |vauthors=Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ |title=The 1982 revised criteria for the classification of systemic lupus erythematosus |journal=Arthritis Rheum. |volume=25 |issue=11 |pages=1271–7 |year=1982 |pmid=7138600 |doi= |url=}}</ref><ref name="pmid9324032">{{cite journal |vauthors=Hochberg MC |title=Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus |journal=Arthritis Rheum. |volume=40 |issue=9 |pages=1725 |year=1997 |pmid=9324032 |doi=10.1002/1529-0131(199709)40:9&lt;1725::AID-ART29&gt;3.0.CO;2-Y |url=}}</ref>
Based on SLICC criteria, diagnosis of SLE is defined as:<ref name="pmid22553077">{{cite journal |vauthors=Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS |title=Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus |journal=Arthritis Rheum. |volume=64 |issue=8 |pages=2677–86 |year=2012 |pmid=22553077 |pmc=3409311 |doi=10.1002/art.34473 |url=}}</ref>
* Meeting at least 4 of 17 criteria, including at least 1 of the 11 clinical criteria and one of the six [[Immunological|immunologic]] criteria 
'''OR'''
* Biopsy-proven [[nephritis]] compatible with [[SLE]] in the presence of [[Antinuclear antibodies|antinuclear antibodies (ANA)]] or [[Double stranded DNA antibody|anti-double-stranded DNA]] (dsDNA) [[antibodies]]
'''A criterion is considered positive if one or more of the observations listed in the definition for the criterion are present in the patient. A criterion should only be counted once, regardless of the number of observations in the definition that the patient presents with.'''
{| class="wikitable"
! align="center" style="background: #4479BA; color: #FFFFFF; " |Category
! align="center" style="background: #4479BA; color: #FFFFFF; " |Criterion
! align="center" style="background: #4479BA; color: #FFFFFF; " |Definition
|-
| rowspan="8" |<small>Clinical</small>
! style="background: #DCDCDC; " | Acute cutaneous lupus
|
* Lupus [[malar rash]]
** Fixed [[erythema]], flat or raised, over the [[malar]] eminences, tending to spare the [[nasolabial folds]]
* [[Bullous]] lupus
* [[Toxic epidermal necrolysis]] variant of SLE
* [[Maculopapular rash|Maculopapular]] lupus [[rash]]
* [[Photosensitive]] lupus [[rash]] (in the absence of [[dermatomyositis]]);
** Skin [[rash]] as a result of unusual reaction to sunlight, by patient history or physician observation  
* Subacute cutaneous lupus
** Nonindurated psoriaform and/or annular polycyclic [[lesions]] that resolve without [[scarring]], although occasionally with [[Postinflammatory hypopigmentation|postinflammatory dyspigmentation]] or [[Telangiectasia|telangiectasias]]
|-
! style="background: #DCDCDC; " |Chronic cutaneous lupus
|
* Classic [[Discoid lupus|discoid rash]]
** Localized (above the neck)
** Generalized (above and below the neck)
** [[Hypertrophic]] (verrucous) lupus
** Lupus [[panniculitis]] (profundus)
** [[Mucosal]] lupus
** [[Lupus erythematosus]] tumidus
** Chilblains lupus OR
** Discoid lupus[[Lichen planus|/lichen planus]] overlap
|-
! style="background: #DCDCDC; " |Nonscarring [[alopecia]]
|
* Diffuse thinning or hair fragility with visible broken hairs (in the absence of other causes, such as [[alopecia areata]], drugs, [[iron deficiency]], and [[androgenic alopecia]])
|-
! style="background: #DCDCDC; " |[[Oral ulcer|Oral]] or nasal ulcers
|
* [[Palate]], [[buccal]], [[tongue]], or nasal [[ulcers]] (in the absence of other causes, such as [[vasculitis]], [[Behçet's disease]], [[infection]], [[inflammatory bowel disease]], [[reactive arthritis]], and acidic foods)
|-
! style="background: #DCDCDC; " |[[Arthralgia|Joint disease]]
|
* [[Synovitis]] involving two or more [[joints]], characterized by [[swelling]] or effusion
* [[Tenderness]] in two or more [[joints]] and at least 30 minutes of morning stiffness
|-
! style="background: #DCDCDC; " |[[Serositis]]
|
* Typical [[pleurisy]] for more than one day, [[Pleural effusion|pleural effusions]], or [[pleural]] rub
* Typical pericardial pain (pain with recumbency improved by sitting forward) for more than one day, [[pericardial effusion]], pericardial rub, or [[pericarditis]] by [[electrocardiography]] in the absence of other causes, such as [[infection]], [[uremia]], and [[Dressler's syndrome]]
|-
! style="background: #DCDCDC; " |[[Renal]]
|
* Urine protein-to-[[creatinine]] ratio (or 24-hour urine protein) representing 500 mg protein/24 hours
* [[Red blood cell]] casts
|-
! style="background: #DCDCDC; " |[[Neurological|Neurologic]]
|
* [[Seizure|Seizures]]
* [[Psychosis]]
* [[Mononeuritis multiplex]] (in the absence of other known causes, such as primary [[vasculitis]])
* [[Myelitis]]
* [[Peripheral neuropathy|Peripheral]] or [[Neuropathy|cranial neuropathy]] (in the absence of other known causes, such as primary [[vasculitis]], [[infection]], and [[diabetes mellitus]]) 
* [[Confusion|Acute confusional state]] (in the absence of other causes, including toxic/metabolic, [[uremia]], drugs)
|-
| rowspan="3" |<small>[[Hematologic]]</small>
! style="background: #DCDCDC; " |[[Hemolytic anemia]]
|
* [[Hemoglobin]] less than 12 g/dL in females and 13 g/dL in males
|-
! style="background: #DCDCDC; " |[[Leukopenia]] or [[lymphopenia]]
|
* [[Leukopenia]] (<4000/mm3 at least once) (in the absence of other known causes, such as [[Felty's syndrome]], [[drugs]], and [[portal hypertension]])
* [[Lymphopenia]] (<1000/mm3 at least once) (in the absence of other known causes, such as [[glucocorticoids]], [[drugs]], and [[infection]])
|-
! style="background: #DCDCDC; " |[[Thrombocytopenia]]
|
* [[Thrombocytopenia]] (<100,000/mm3) at least once in the absence of other known causes, such as [[drugs]], [[portal hypertension]], and [[thrombotic thrombocytopenic purpura]]
|-
| rowspan="6" |<small>[[Immunological|Immunologic]]</small>
! style="background: #DCDCDC; " |[[ANA]]
|
* [[ANA]] level above laboratory reference range
|-
! style="background: #DCDCDC; " |[[Anti-dsDNA antibody|Anti-dsDNA]]
|
* [[Anti-dsDNA antibody]] level above laboratory reference range (or >twofold the reference range if tested by [[Enzyme linked immunosorbent assay (ELISA)|ELISA]])
|-
! style="background: #DCDCDC; " |Anit-SM
|
* Presence of [[antibody]] to [[Smith antigen|Sm nuclear antigen]]
|-
! style="background: #DCDCDC; " |[[Antiphospholipid antibody|Antiphospholipid]]
|
* [[Antiphospholipid antibodies|Antiphospholipid antibody]] positivity as determined by any of the following:
** Positive test result for [[lupus anticoagulant]]
** False-positive test result for [[rapid plasma reagin]]
** Medium- or high-titer [[anticardiolipin antibody]] level ([[IgA]], [[IgG]], or [[IgM]])
** Positive test result for anti-beta 2-glycoprotein I ([[IgA]], [[IgG]], or [[IgM]])
|-
! style="background: #DCDCDC; " |Low [[complement]]
|
* Low [[C3 glomerular disease|C3]]
* Low [[C4 disease|C4]]
* Low CH50
|-
! style="background: #DCDCDC; " |[[Coombs' Test|Direct Coombs' test]]
|
* [[Coombs' Test|Direct Coombs' test]] in the absence of [[hemolytic anemia]]
|}


=== Complete diagnostic approach: ===
=== Complete diagnostic approach: ===

Revision as of 17:15, 30 March 2018

SLE
Resident Survival Guide
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Overview

Causes

  • Exposure to ultraviolet (UV) light[3]
    • Can exacerbate or induce systemic manifestations of SLE 
  • Drug-induced lupus

FIRE

Diagnosis

Diagnostic criteria:

In 2012, Systemic Lupus International Collaboration Criteria (SLICC) developed a new criteria for SLE diagnosis. SLICC criteria for the classification of systemic lupus erythematosus was developed based on the old ACR criteria for the classification of systemic lupus erythematosus to address a more sensitive diagnostic criteria and also to cover weaknesses of the previous ACR criteria.[4][5]

Based on SLICC criteria, diagnosis of SLE is defined as:[6]

  • Meeting at least 4 of 17 criteria, including at least 1 of the 11 clinical criteria and one of the six immunologic criteria 

OR

A criterion is considered positive if one or more of the observations listed in the definition for the criterion are present in the patient. A criterion should only be counted once, regardless of the number of observations in the definition that the patient presents with.

Category Criterion Definition
Clinical Acute cutaneous lupus
Chronic cutaneous lupus
Nonscarring alopecia
Oral or nasal ulcers
Joint disease
Serositis
Renal
Neurologic
Hematologic Hemolytic anemia
  • Hemoglobin less than 12 g/dL in females and 13 g/dL in males
Leukopenia or lymphopenia
Thrombocytopenia
Immunologic ANA
  • ANA level above laboratory reference range
Anti-dsDNA
Anit-SM
Antiphospholipid
Low complement
  • Low C3
  • Low C4
  • Low CH50
Direct Coombs' test

Complete diagnostic approach:

Treatment

Do's

Don'ts

References

  1. Schur PH (1995). "Genetics of systemic lupus erythematosus". Lupus. 4 (6): 425–37. doi:10.1177/096120339500400603. PMID 8749564.
  2. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT (1995). "Estrogens, the immune response and autoimmunity". Clin. Exp. Rheumatol. 13 (2): 217–26. PMID 7656468.
  3. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS (2002). "Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history". J Clin Epidemiol. 55 (10): 982–9. PMID 12464374.
  4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982). "The 1982 revised criteria for the classification of systemic lupus erythematosus". Arthritis Rheum. 25 (11): 1271–7. PMID 7138600.
  5. Hochberg MC (1997). "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus". Arthritis Rheum. 40 (9): 1725. doi:10.1002/1529-0131(199709)40:9&lt;1725::AID-ART29&gt;3.0.CO;2-Y. PMID 9324032.
  6. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS (2012). "Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus". Arthritis Rheum. 64 (8): 2677–86. doi:10.1002/art.34473. PMC 3409311. PMID 22553077.